MEDICINES DISCOVERY CATAPULT SERVICES COMMERCIAL LIMITED

PaymentCheck Score 2023
100Excellent
2.0vs last year
#14 in UK
#1 in North West

Company Information

Company Number
13568417
Registered Address
Block 35g, Mereside Alderley Park, Alderley Edge, Macclesfield, Cheshire, United Kingdom, SK10 4ZF
Status
Active
Employee Count
0
Turnover
£3,326,787
EBITDA
£761,140

Additional Details

Company Type
Private limited Company
Incorporated On
16 August 2021
Nature of Business
72190 - Other research and experimental development on natural sciences and engineering
Industries
Coming Soon
Region
North West

Time to Pay

Average Time to Pay
4 days
Shortest Period:0 days
Longest Period:30 days
Max Contractual:30 days

Payment Timeline

Within 30 Days
100%
31-60 Days
0%
After 60 Days
0%
Not Paid Within Terms0%

Payment Features

Participates in Codes✗ No
E-Invoicing✓ Yes
Supply Chain Finance✗ No

Payment Score History

Excellent (80+) Good (60-79) Fair (40-59) Poor (20-39) Very Poor (<20)

Company Review

Trend Analysis

The average time taken for Medicines Discovery Catapult Services Commercial Limited to pay invoices has decreased from 10 days in Oct 2021-Mar 2022 to 4 days in Apr-Sep 2023. This shows a consistent trend of improvement in payment times over the three periods analyzed.

Volatility Analysis

There is very little volatility in the data for Medicines Discovery Catapult Services Commercial Limited. The company consistently pays 100% of invoices within 30 days and has no invoices paid later than 60 days or not within agreed terms over the three periods analyzed.

Summary Analysis

In the three periods analyzed, Medicines Discovery Catapult Services Commercial Limited has shown a consistent trend towards improving their payment times. The average time taken to pay invoices has decreased from 10 days to 4 days. This improvement is also reflected in the percentage of invoices paid within 30 days, which has consistently been at 100%. There has been a slight increase in the percentage of invoices paid between 31 and 60 days, from 0% to 10%, in the second period analyzed. However, this is still a low percentage and does not significantly impact the overall trend of improvement.

Performance Reports History

Reporting Period Filed: 2023-10-23
Reporting PeriodFiling DateAverage Time to Pay (days)Paid within 30 daysPaid 31-60 daysPaid after 60 daysNot Paid within Terms
01 Apr 2023 - 30 Sept 202323 Oct 20234100%0%0%0%
01 Oct 2022 - 31 Mar 202328 Apr 20239100%0%0%0%
01 Apr 2022 - 30 Sept 202230 Nov 20221290%10%0%0%
01 Oct 2021 - 31 Mar 202221 Apr 202210100%0%0%0%

Payment Time Trends

Payment Distribution Trends

Invoice Payment Practices

This information is as reported by the business, and responses are in their own words.

Payment Terms

Standard payment terms

30 days from invoice date

Were there any changes to the standard payment terms in the reporting period?

No

Any other information about payment terms

n/a

Maximum contractual payment period agreed

30

Dispute Resolution Process

all disuptes should be sent to accountspayable@md.catapult.org.uk email address and will be responded to within 24 hours

Other Payment Information

Has this business signed up to a code of conduct or standards on payment practices?

For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.

Does this business offer e-invoicing in relation to qualifying contracts?

This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.

Does this business offer supply chain finance?

This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.

Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?

During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?

No information available

Company Summary

MEDICINES DISCOVERY CATAPULT SERVICES COMMERCIAL LIMITED is a UK-based organization that focuses on accelerating the discovery and development of new medicines. They offer a range of services to support the pharmaceutical and biotech industries, including drug discovery and development, clinical trials, and commercialization.

The company has a strong focus on sustainability and is committed to reducing the environmental impact of their operations. They have implemented various initiatives to reduce waste and promote energy efficiency, as well as promoting sustainable sourcing and production practices within the pharmaceutical industry.

MEDICINES DISCOVERY CATAPULT SERVICES COMMERCIAL LIMITED has a team of highly experienced and knowledgeable individuals, including scientists, engineers, and business professionals. They work closely with their clients to provide tailored solutions and drive innovation in the field of medicine development.

Their products and services include drug discovery and development support, clinical research services, and access to state-of-the-art facilities and technologies. They also offer training and consultancy services to help companies improve their drug discovery processes and increase their chances of success.

For more information on their services and sustainability program, interested parties can visit their website at www.mdcatservices.co.uk. The company's registered office address is located at Block 38 Office G.1, Kelvin Campus, West of Scotland Science Park, Glasgow, G20 0SP, United Kingdom.

Financial Metrics

Cash
£1,755,978
Net Worth
£807,928
Total Current Assets
£2,361,568
Total Current Liabilities
£1,553,640

Company Location